October 28, 2002
On October 24, 2002, the Canadian Nuclear Safety Commission (CNSC) issued to Atomic Energy of Canada Ltd. (AECL), an approval to resume commissioning activities at the MAPLE 1 Reactor. This approval was given by the Director General of Nuclear Cycle and Facilities Regulation under authority delegated by the Commission.
The MAPLE 1 Reactor, in Chalk River, Ontario, is designed to produce medical isotopes for use in nuclear medicine.
Before issuing this approval, CNSC staff performed a thorough review of the state of the MAPLE 1 Reactor, the qualification of AECL staff to operate the reactor, and the overall management of the project by AECL.
Based on this review, it was determined that the restart of commissioning could proceed safely.
Accordingly, CNSC staff recommended that the Director General of Nuclear Cycle and Facilities Regulation approve removal of the MAPLE 1 Reactor from an approved shutdown state, pursuant to Licence Condition C3 of licence NPROL-62.02/2003.
For more information contact:
Director, Research Facilities Division
Canadian Nuclear Safety Commission
(613) 943-2923 or 1 (800) 668-5284